Molsidomine - Vectura

Drug Profile

Molsidomine - Vectura

Alternative Names: Coruno

Latest Information Update: 14 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator SkyePharma PLC
  • Developer Therabel
  • Class Heart failure therapies; Ischaemic heart disorder therapies; Morpholines; Small molecules; Sydnones; Vasodilators
  • Mechanism of Action Nitric oxide donors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Angina pectoris

Most Recent Events

  • 20 Jan 2004 Launched for Angina pectoris in Belgium (PO)
  • 17 Oct 2002 Registered for Angina pectoris in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top